Clinical Trials · NCT02874326
Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Radboud University Medical Center
- Enrollment
- 15
- Start date
- Oct 2016
- Locations
- 2 sites, Netherlands
- Primary endpoint
- The percentage of patients who are full responder, partial responder and non-responder at the end of the treatment period